Profusa (PFSA) Receivables - Other (2021 - 2025)

Profusa (PFSA) posted quarterly Receivables - Other of $428000.0 for Q3 2025, up 1612.0% quarter-over-quarter from $25000.0 in Q1 2022.

Profusa (PFSA) Receivables - Other (2021 - 2025) Analysis & Trends

Profusa's Receivables - Other history runs 3 years deep, the most recent figure standing at $428000.0 for Q3 2025.

In Q3 2025, Receivables - Other changed N/A year-over-year to $428000.0; the TTM figure through Sep 2025 stood at $428000.0 (changed N/A YoY), while the FY2024 annual figure was -$45000.0, changed N/A from the prior year.
Receivables - Other for Q3 2025 stood at $428000.0, up from $25000.0 in the prior quarter.
The five-year high for Receivables - Other was $428000.0 in Q3 2025, with the low at $25000.0 in Q4 2021.
The 3-year median for Receivables - Other is $25000.0 (2021), against an average of $159333.3.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.25 Bn	196.65 Bn	7.27 Bn
2	Stryker	127.36 Bn	123.89 Bn	4.50 Bn
3	Medtronic	119.03 Bn	109.81 Bn	6.41 Bn
4	Boston Scientific	74.45 Bn	73.91 Bn	3.85 Bn
5	Edwards Lifesciences	51.81 Bn	47.55 Bn	1.35 Bn
6	Dexcom	35.04 Bn	33.10 Bn	830.00 Mn
7	GE HealthCare Technologies	33.84 Bn	31.73 Bn	2.18 Bn
8	Koninklijke Philips	26.25 Bn	22.93 Bn	4.55 Bn
9	Steris	23.18 Bn	22.70 Bn	684.20 Mn
10	Profusa	97,698.79	-277,301.21	-

Download Data